NCT06129838View on ClinicalTrials.gov

Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Alzheimer Disease
Interventions
DRUG

[11C]-CS1P1

Participants will receive a single intravenous bolus injection of 12.0 - 17.0 milliCurie (mCi) of the investigational radiotracer \[11C\]-CS1P1. Participants will then undergo a brain \[11C\]-CS1P1 PET scan

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER